Reg FD Disclosure

Securities and Exchange Commission, the information in this Item 7.01 disclosure, including Exhibit 99.1 and information set forth therein, is deemed to have been furnished and shall not be deemed to be “filed” under the Securities Exchange Act of 1934, as amended. Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 2020 Annual Meeting of Stockholders presentation slides SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 24, 2020 PROVECTUS BIOPHARMACEUTICALS, INC. By: /s/ Heather Raines Heather Raines Chief Financial Officer (Principal Financial Officer)